Acknowledgments
Contributors
Introduction
Why amphetamine-type stimulants?
by Steve Allsop and Nicole Lee
PART 1 INTRODUCTION TO AMPHETAMINE-TYPE STIMULANTS: INFLUENCES ON THEIR ACTION AND EFFECTS
Chapter 1 Amphetamine-type stimulant use on a global level and implications for responding
by Rebecca McKetin, Amanda Baker, Frances Kay-Lambkin, and Nicole Lee
Chapter 2 Pharmacology of amphetamine-type stimulants and implications for harms and responses
by Irina Majumder and Jason M White
Chapter 3 Neurocognitive effects of amphetamine-type stimulants and implications for intervention
by Dean S Carson, Daniel F. Hermens, Adam J. Guastella, David P. Bosanquet, and Iain S. McGregor
Chapter 4 The social contexts and cultural meanings of amphetamine-type stimulant use and their implications for policy and practice
by Robyn Dwyer, Amy Pennay, Rachael Green, Christine Siokou, Monica Barratt, Nicola Thompson, and David Moore
Chapter 5 Amphetamine-type stimulant use and risk-taking behaviours
by Libby Topp
Chapter 6 Ups and downs: physical and mental health consequences of amphetamine-type stimulant use
by Linda Jenner
Chapter 7 Effects of amphetamine-type stimulant use and problems for the individual, family, and community
by Paula Ross
Chapter 8 The role of health economics in understanding and responding to amphetamine-type stimulants
by Chris Doran
PART 2 PERSONAL PRSPECTIVES
Chapter 9 A line before work: my functional life using methamphetamine
by ‘Alice’
Chapter 10 Making use of speed skilfully to interrogate and embrace life
by ‘Ned Winger’
Chapter 11 MDMA: a tale of controlled hedonism
by ‘Chris’
Chapter 12 Living with amphetamine problems – a family’s story
by ‘Susan McFarlaine’
Chapter 13 The impact of amphetamine-type stimulants on operational policing: a personal choice for which everyone pays
by Corey Allen
Chapter 14 The impact of amphetamine-type stimulants on ambulance services
by Alan Eade
Chapter 15 The impact of amphetamine-type stimulant use on emergency department services
by Jason Armstrong and Kane Guthrie
Chapter 16 The impact of amphetamine-type stimulant use on mental health services
by Brendan Pawsey and Christopher Hynan
PART 3 EVIDENCE TO INFORM RESPONSES TO HARM RELATED TO AMPHETAMINE-TYPE STIMULANTS
Chapter 17 The impact of amphetamine-type stimulant use on law enforcement: patterns and responses
by Toni Makkai and Jennifer Beattie
Chapter 18 Prevention and public health approaches to amphetamine-type stimulant use and related harm
by Steve Allsop
Chapter 19 Clinical responses to amphetamine-type stimulant problems
by Nicole Lee and Linda Jenner
Chapter 20 Pharmacotherapy of amphetamine-type stimulants
by Matthew Brensilver, Victoria Johnson, Annette Grotheer, Keith G Heinzerling, Michelle Anne Bholat, and Stephen Shoptaw
PART 4 CHALLENGES IN MANAGEMENT: PRACTICAL APPROACHES TO CARE
Chapter 21 Effective responses in general health and other mainstream services
by Robert Ali, Sonali Meena, and Linda Gowing
Chapter 22 Opportunistic interventions for methamphetamine use: reducing the risks
by Amy Pennay, Dan I. Lubman, and Tiffany Reichert
Chapter 23 Taking a reinforcing approach to treatment entry and retention
by Martin Iguchi
Chapter 24 Engaging methamphetamine users in treatment and managing the challenges
by Glenys Dore and Lisa Juckes
Chapter 25 Treatment and care for young amphetamine-type stimulant users
by Andrew Bruun, Dominic Ennis, Horace Wansborough, Rachael Green, and Penny Mitchell
Chapter 26 Working with same sex-attracted, sex and gender diverse persons
by John Howard, Atari Metcalf, Simon Beck, and Angela Matheson
Chapter 27 Working with people affected by co-occurring amphetamine-type stimulant and mental health problems
by Lisa Juckes
Chapter 23 Stepped-care approaches for amphetamine-type stimulant problems
By Amanda Baker, Frances Kay-Lambkin, Madeleine de Ville, Rebecca McKetin, and Nicole Lee
References
Index |
